A leading pharmaceutical manufacturer accelerated its renewable energy transition by adopting an innovative zero-capex solar financing model — unlocking guaranteed performance and delivering over ₹25 crores in lifetime savings.
Case
The company wanted to reduce rising energy costs at its flagship manufacturing facility in Baddi, a major industrial hub in North India and had been evaluating a solar asset on their premises. This was not only important to keep their input costs low for global competitiveness, they also wanted to reduce their carbon footprint. Despite being a strategic priority, capital constraints had prevented them from moving forward with a traditional CAPEX investment for years. The company was evaluating a third-party PPA proposal and felt convinced about the viability of the model.
Solution
TW.O designed and deployed a 1.1 MW onsite solar asset, financed through an an innovative solar lease model. This model, with guaranteed outcomes and a shorter tenure, not only enabled the client to access a state-of-the-art solar plant at zero upfront cost, it also enabled a TCO 60% lower than the PPA proposal they had on the table. To further de-risk execution and quality of operations, TW.O ensured a high asset quality by onboarding a Tier-1 EPC partner and Tier-1 equipment. Beyond financing and EPC selection, TW.O also supported the client across regulatory coordination, performance assurance, and long-term asset oversight, allowing the client to sit back, relax and enjoy the fruits of going solar!
Impact
₹25+ crore in total savings delivered over the life of the solar asset
Best-in-class Total Cost of Ownership, ~60% lower than PPA and ~80% lower than grid power
21,000 tonnes of carbon emissions abated, equivalent to planting over 5,00,000 trees
Outcomes: Guaranteed
